Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
BI 764532 for Small Cell Lung Cancer
Recruiting1 awardPhase 1
Pittsburgh, Pennsylvania
This trial is exploring a new drug, BI 764532, to determine the maximum tolerated dose and the recommended dose for expansion. The goal is to also document the drug's safety and efficacy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.